Brent Saunders
Chairman & CEO
Bausch + Lomb
Curran Simpson
President & CEO
REGENXBIO
Elizabeth Naldi-Jacob
VP & Head, HQ Transactions & Corporate Development
Merck
Eric Tokat
Co-President
Centerview Partners
Frank Jiang
EVP, Chief Strategy Officer
Jiangsu Hengrui Pharmaceuticals
Fred Ramsdell
Nobel Laureate & Scientific Advisor
Sonoma Biotherapeutics
Harsh Gandhi
Global Head of Commercial Excellence & Digital Marketing Technologies
AstraZeneca
Heather Turner
CEO
LB Pharmaceuticals Inc
Hilary Marston
Principal, Drugs & Biologics
Canal Row Advisors
Ivana Magovčević-Liebisch
President & CEO
Draig Therapeutics
Joe Ferraro
VP of Product
Salesforce
Johanna DeYoung
Global Industry Lead, Healthcare & Life Sciences
Slalom
John Connolly
Chief Scientific Officer
Parker Institute for Cancer Immunotherapy
Karin Shanahan
EVP, Chief Supply Chain & Operations Officer
Bristol Myers Squibb
Mike Doustdar
President & CEO
Novo Nordisk A/S
Nicholas Donoghoe
EVP, Chief Business & Strategy Officer
AbbVie
Noubar Afeyan
Founder & CEO
Flagship Pioneering
Puja Sapra
SVP, Biologics Engineering & Oncology Targeted Discovery
AstraZeneca
Rachna Khosla
SVP, Head of Business Development
Amgen
Reenie McCarthy
CEO
Stealth BioTherapeutics
Robert Nelsen
Co-Founder & Managing Director
ARCH Venture Partners
Tarek Rabah
President & CEO
Otsuka North America Pharmaceutical Business
Presenting Speaker
Tom Randall
Head of Endpoints Signal
Endpoints News
Tony Wood
Chief Scientific Officer
GSK
Victor Bulto
President, US
Novartis
Vijay Pande
Co-Founder & Managing Partner
VZVC
Yusri Elsayed
SVP, Global Head of Oncology Therapeutic Area, R&D
Johnson & Johnson Innovative Medicine